SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:20
1251.05
13 (1.05%)
VOLUME 39,359
LIVE
NSE
Aug 21, 15:57
1237.70
-8.35 (-0.67%)
VOLUME 293,502
News on Lupin
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Checkout: Religare Capital's top pharma bets 

3.35 pm | 21 Aug 2014 |  Source: CNBC-TV18

Arvind Bothra picks Aurobindo Pharma as his favourite bet among midcaps and Sun Pharma and Lupin among large caps....

Shasun Pharma may go to Rs 215-220: Ambareesh Baliga 

10.15 am | 21 Aug 2014 |  Source: CNBC-TV18

Market expert, Ambareesh Baliga feels that Shasun Pharmaceuticals may go to Rs 215-220 where one should book out completely....

Prefer Sun Pharma, Lupin: Tirthankar Patnaik 

1.16 pm | 14 Aug 2014 |  Source: CNBC-TV18

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets prefers Sun Pharmaceutical Industries and Lupin from the pharmaceuti...

Buy Lupin 1180 Call, says VK Sharma 

11.45 am | 14 Aug 2014 |  Source: CNBC-TV18

VK Sharma of HDFC Securities is of the view that one may buy Lupin 1180 Call....

See Nifty at 8000 by Dec; bullish cement, pharma: Religare 

10.22 am | 14 Aug 2014 |  Source: CNBC-TV18

Patnaik feels a further reduction in monetary stimulus in the US will trigger a knee jerk reaction in emerging markets...

Why capex of top 20 Indian pharma firms is set to jump 40%

3.05 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Out of this lot of 20, the capex spending of 8 companies – which currently generate a majority of revenues domestically – will almost double by fi...

Mkt undertone buoyant; like Lupin, Infy, avoid BHEL: Emkay 

11.47 am | 13 Aug 2014 |  Source: CNBC-TV18

Sachin Shah, fund manager at Emkay Investment Managers says the undertone of the market continues to be buoyant, with positive net flows and a fairly ...

Sun Pharma long term buy: Gopi Suvanam 

11.23 am | 13 Aug 2014 |  Source: CNBC-TV18

According to Gopi Suvanam of InvestWorks, Sun Pharmaceutical Industries is a long term buy and feels that one may build position in Cipla....

Investors likely to favour China; see rate hikes in US: F&C 

10.51 am | 12 Aug 2014 |  Source: CNBC-TV18

Chowdhry says the the recent Union Budget was a tad disappointing and that policy decisions will take time to come through...

Hold Lupin; target of Rs 1289: ICICIdirect

4.32 pm | 07 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Lupin with a target price of Rs 1289, in its research report dated July 31, 2014....

Lupin inks pact with S Korean firm to launch diabetes drug

2.30 pm | 06 Aug 2014 |  Source: PTI

As per the strategic distribution pact inked between the two companies, Mumbai-based Lupin will launch LG Life Sciences' Insulin Glargine, a novel ins...

Lupin launches Basugine

1.59 pm | 06 Aug 2014 |  Source: Moneycontrol.com

Lupin today announced a strategic distribution agreement with LG Life Sciences to launch insulin Glargine under the brand name Basugine....

Amit Khurana neutral on IT space 

1.54 pm | 06 Aug 2014 |  Source: CNBC-TV18

Amit Khurana, Co- Head Equites & Head of Research at Dolat Capital Market has a neutral view on IT space....

Prefer Lupin, says Amit Khurana 

1.50 pm | 06 Aug 2014 |  Source: CNBC-TV18

Amit Khurana, Co- Head Equites & Head of Research at Dolat Capital Market prefers Lupin and Biocon....

Expect upmove in Sun Pharma: Sudarshan Sukhani 

10.59 am | 06 Aug 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may see upmove in Sun Pharma....

Ten stocks to keep an eye on August 6 

8.47 am | 06 Aug 2014 |  Source: CNBC-TV18

Here are top 10 stocks to focus on August 6 - HDIL, Lupin, Infosys, Hero Moto, Bata, KRBL, Jubilant Life, Crompton Greaves, Hanung Toys and Capital Fi...

Buy Lupin; target of Rs 1285: Firstcall Research

7.23 pm | 05 Aug 2014 |  Source: Moneycontrol.com

Firstcall Research is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 1285 in its August 1, 2014 research report....

Hold Lupin, buy Dishman Pharma: Ambareesh Baliga 

4.59 pm | 04 Aug 2014 |  Source: CNBC-TV18

Independent Market Expert, Ambareesh Baliga is of the view that one may buy Dishman Pharmaceuticals & Chemicals. He advises holding Lupin....

Buy Lupin; target of Rs 1365: Religare Capital

3.38 pm | 04 Aug 2014 |  Source: Moneycontrol.com

Religare Capital is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 1365 in its July 31, 2014 research report....

Lupin, Dr Reddy's Labs may outperform: Sandip Sabharwal 

11.53 am | 04 Aug 2014 |  Source: CNBC-TV18

Market Expert, Sandip Sabharwal is of the view that Lupin and Dr Reddy's Laboratories could be outperformers going forward....

1 2 3 4 5 6
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.